High dose cabergoline therapy for a resistant macroprolactinoma during pregnancy.
Banerjee
A
A
Wynne
K
K
Tan
T
T
Hatfield
E C
EC
Martin
N M
NM
Williamson
C
C
Meeran
K
K
D000328:Adult; D000077465:Cabergoline; D004873:Ergolines / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications / Q000188:drug therapy; D007231:Infant, Newborn; D010911:Pituitary Neoplasms / Q000150:complications* / Q000188:drug therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011388:Prolactin / Q000037:antagonists & inhibitors; D015175:Prolactinoma / Q000150:complications* / Q000188:drug therapy*
D004873:Ergolines; D011388:Prolactin; D000077465:Cabergoline